Stock Taper 
PATIENT SQUARE CAPITAL LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 argenx SE | ARGX | 23K | $21.34M |
 United Therapeutics Corporation | UTHR | 37.12K | $20.11M |
 Kymera Therapeutics, Inc. | KYMR | 47.5K | $5.45M |
 BeOne Medicines AG | ONC | 90.02K | $25.65M |
 Dianthus Therapeutics, Inc. | DNTH | 108K | $10.53M |
 BioNTech SE | BNTX | 134.43K | $12.51M |
 Abivax S.A. | ABVX | 206.5K | $27.52M |
 Enliven Therapeutics, Inc. | ELVN | 212.5K | $10.78M |
 Xenon Pharmaceuticals Inc. | XENE | 220K | $13.28M |
 Mirum Pharmaceuticals, Inc. | MIRM | 260.5K | $30.5M |
 Revolution Medicines, Inc. | RVMD | 276K | $51.69M |
 Arcus Biosciences, Inc. | RCUS | 355.8K | $10.97M |
 Arcutis Biotherapeutics, Inc. | ARQT | 370K | $9.7M |
 Cogent Biosciences, Inc. | COGT | 425K | $16.45M |
 Pharvaris N.V. | PHVS | 671.21K | $23.21M |
 EyePoint Pharmaceuticals, Inc. | EYPT | 720K | $10.3M |
 C4 Therapeutics, Inc. | CCCC | 1.61M | $7.51M |
 Allogene Therapeutics, Inc. | ALLO | 5.05M | $10.5M |
 Roivant Sciences Ltd. | ROIV | 8.02M | $283.86M |